3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
68
Carcinoma, Non-Small-Cell Lung
41
Carcinoma, Renal Cell
36
Neoplasm Metastasis
22
Carcinoma, Hepatocellular
15
Neoplasms
14
Colorectal Neoplasms
13
Brain Neoplasms
13
Skin Neoplasms
12
Squamous Cell Carcinoma of Head and Neck
11
Pancreatic Neoplasms
10
Lung Neoplasms
10
Kidney Neoplasms
10
Uveal Melanoma
9
Ovarian Neoplasms
9
Urinary Bladder Neoplasms
8
Sarcoma
8
Prostatic Neoplasms
8
Carcinoma, Transitional Cell
8
Mesothelioma
7
Glioblastoma
7
Clear-cell metastatic renal cell carcinoma
7
Carcinoma, Merkel Cell
7
Recurrence
6
Colonic Neoplasms
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Myelodysplastic Syndromes
5
Multiple Myeloma
5
Mesothelioma, Malignant
5
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Temozolomide
2
LY3023414
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
amino-acid, glucose, and electrolyte solution
1
Vincristine
1
Vemurafenib
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Ipilimumab
×
1 year
×
Clear all
No trials found.